Trial intelligence / Profile preview

Ursodeoxycholic acid versus metformin for gestational diabetes in overweight or obese pregnant women

2019-002880-82Phase 4Unknown

Sponsor
King's College London
Start
Jun 2020
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in gestational diabetes mellitus (GDM) comparing Ursofalk arm with Metformin arm (2 arms). Primary endpoint: Maternal fasting glucose concentration. Status: unknown.

02

Drugs

ursodeoxycholic acidmetformin
03

Conditions

gestational diabetes mellitus (GDM)

Beyond the preview

Go deeper on 2019-002880-82.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2019-002880-82.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call